3-46671945-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_147129.5(ALS2CL):āc.2623G>Cā(p.Glu875Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_147129.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALS2CL | NM_147129.5 | c.2623G>C | p.Glu875Gln | missense_variant | 24/26 | ENST00000318962.9 | NP_667340.2 | |
ALS2CL | NM_001190707.2 | c.2623G>C | p.Glu875Gln | missense_variant | 24/26 | NP_001177636.1 | ||
ALS2CL | NR_033815.3 | n.2971G>C | non_coding_transcript_exon_variant | 24/26 | ||||
ALS2CL | NR_135622.2 | n.3559G>C | non_coding_transcript_exon_variant | 23/25 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALS2CL | ENST00000318962.9 | c.2623G>C | p.Glu875Gln | missense_variant | 24/26 | 1 | NM_147129.5 | ENSP00000313670.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461766Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727198
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | The c.2623G>C (p.E875Q) alteration is located in exon 24 (coding exon 23) of the ALS2CL gene. This alteration results from a G to C substitution at nucleotide position 2623, causing the glutamic acid (E) at amino acid position 875 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at